1. Setchell KDR. Soy isoflavones — benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 2001; 20(5 Suppl):354S-362S.
2. Setchell KDR, Lawson AM, Mitchell FL, Adlercreutz H, Kirk DN, Axelson M. Lignans in man and in animal species. Nature 1980; 287:740-742.
3. Setchell KDR, Borriello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 1984; 40:569-578.
4. Thompson L. Flaxseed, lignans, and cancer. In Flaxseed in Human Nutrition, 2nd ed. SC Cunnane, LU Thompson, eds. Champaign, IL: AOCS Press; 2003:194-222.
5. Bhatty RS. Nutrient composition of whole flaxseed and flaxseed meal. In Flaxseed in Human Nutrition. SC Cunnane, LU Thompson, eds. Champaign, IL: AOCS Press; 1995:22-42.
6. Thompson LU, Robb P, Serriano M, and Cheung F. Mammalian lignan production for various foods. Nutr Cancer 1991; 16:43-52.
7. Mazur W. Phytoestrogen content in foods. Bailliere's Clin Endocrin Metab 1998; 12:729-742.
8. Adlercreutz H, Fotsis T, Heikkinen B, Dwyer JR, Wood M, Goldin BR, Gorbach SL. Excretion of the lignans enterolactone and enterdiol and of equol in omnivorous and vegetarian women and in women with breast cancer. Lancet 1982; 2:1295-1299.
9. Johnston PV. Flaxseed oil and cancer: a-linolenic acid and carcinogenesis. In Flaxseed in Human Nutrition. SC Cunnane, LU Thompson, eds. Champaign, IL: AOCS Press; 1995:207-218.
10. Setchell KDR. Discovery and potential clinical importance of mammalian lignans. In Flaxseed in Human Nutrition. SC Cunnane, LU Thompson, eds. Champaign, IL: AOCS Press; 1995:82-98.
11. Meagher LP, Beecher GR, Flanagan VP, Li BW. Isolation and characterization of the lignans, isolariciresinol and pinoresinol, in flaxseed meal. J Agric Food Chem 1999; 47:3173-3180.
12. Thompson LU. Analysis and bioavailability of lignans. In Flaxseed in Human Nutrition, 2nd ed. SC Cunnane, LU Thompson, eds. Champaign, IL: AOCS Press; 2003:92-116.
13. Rickard SE, Orcheson LJ, Seidl MM, Luyengi L, Fong HH, Thompson LU. Dose-dependent production of mammalian lignans in rats and in-vitro from the purified precursor secoisolariciresinol diglycoside from flaxseed. J Nutr 1996; 126:2012-2019.
14. Jordan VC, Morrow M. Tamoxifen, raloxifene, and the prevention of breast cancer. Endocr Rev 1989; 20:253-278.
15. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstorm O, Ohman L, Greene GL, Gustafsson JA, Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997; 389:753-758.
16. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstorm O, Ljunngren J, Gustafsson JA, Carlquist M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 1999; 18:4608-4618.
17. Brzezinski A, Debi A. Phytoestrogens: the "natural" selective estrogen receptor modulators? Eur J Obstet Gynecol Reprod Biol 1999; 85:47-51.
18. Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple outcomes of raloxifene evaluations. J Am Med Assoc 1999; 281:2189-2197.
19. Axelson M, Setchell KD. Conjugation of lignans in human urine. FEBS Lett 1980; 122:49-53.
20. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 2002; 3:364-373.
21. Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994; 60:333-340.
22. Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 2004; 12:1559-1567.
23. Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH, Seow A, Lee HP, Yu MC. Mam-mographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiol Biomarkers Prev 2002; 11:608-613.
24. Boyd NF, Stone J, Vogt KN, Connelly BS, Martin LJ, Minkin S. Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br J Cancer 2003; 89:1672-1685.
25. Dai Q, Shu XO, Jin F, Potter JD, Kushi LH, Teas J, Gao YT, Zheng W. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 2001; 85:372-378.
26. Key TJ, Sharp GB, Appleby PN, Beral V, Goodman MT, Soda M, Mabuchi K. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer 1999; 81:1248-1256.
27. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast-cancer risk in Singapore. Lancet 1991; 337:1197-1200.
28. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore. Cancer Causes Control 1992; 3:313-322.
29. Hirose K, Tajima K, Hamajima N, Inoue M, Takezaki T, Kuroishi T, Yoshida M, Tokudome S. A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn J Cancer Res 1995; 86:146-154.
30. Yuan J-M, Wang Q-S, Ross RK, Henderson BE, Yu MC. Diet and breast cancer in Shanghai and Tiajin. China. Br J Cancer 1995; 71:1353-1358.
31. Jenkins DJ, Kendall CW, D'Costa MA, Jackson CJ, Vidgen E, Singer W, Silverman JA, Koumbridis G, Honey J, Rao AV, Fleshner N, Klotz L. Soy consumption and phytoestrogens: effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic men. J Urol 2003; 169:507-511.
32. Urban D, Irwin W, Kirk M, Markiewicz MA, Myers R, Smith M, Weiss H, Grizzle WE, Barnes S. The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen. J Urol 2001; 165:294-300.
33. Kumar NB, Cantor A, Allen K, Riccardi D, Besterman-Dahan K, Seigne J, Helal M, Salup R, Pow-Sang J. The specific role of isoflavones in reducing prostate cancer risk. Prostate 2004; 59(2):141-147.
Reinli K, Block G. Phytoestrogen content of foods — a compendium of literature values. Nutr Cancer 1996; 26:123-148.
Severson RK, Nomura AMY, Grove JS, Stemmermann GN. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989; 9:545-552.
Jacobsen BK, Knutsen SF, Fraser GE. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control 1998; 9:553-557.
Matsuzaki Y, Kurokawa N, Terai S, Matsumura Y, Kobayashi N, Okita K. Cell death induced by baicalein in human hepatocellular carcinoma cell lines. Jpn J Cancer Res 1996; 87:170-177.
Kuntz S, Wenzel U, Daniel H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur J Nutr 1999; 38:133-142.
Nagata C, Takatsuka N, Kawakami N, Shimizu H. A prospective cohort study of soy product intake and stomach cancer death. Br J Cancer 2002; 87:31-36. Xu WH, Zheng W, Xiang YB, Ruan ZX, Cheng JR, Dai Q, Gao YT, Shu XO. Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. Br Med J 2004 May 29; 328(7541):1285. Horn-Ross PL, John EM, Canchola AJ, Stewart SL, Lee MM. Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 2003; 95:1158-1164. Ross JA. Dietary flavonoids and the MLL gene: A pathway to infant leukemia? Proc Natl Acad Sci USA 2000; 97:4411-4413.
Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci USA 2000; 97:4790-4795.
Schroder-van der Elst JP, van der Heide D, Rokos H, Morreale de Escobar G, Kohrle J. Synthetic flavonoids cross the placenta in the rat and are found in fetal brain. Am J Physiol 1998; 274:E253-E256.
Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995; 125(3 Suppl):777S-783S.
Chen JM, Stavro M, Thompson LU. Dietary flaxseed inhibits breast cancer growth and metastasis and downregulates expression of epidermal growth factor receptor and insulin-like growth factor. Nutr Cancer 2002; 43;187-192. Yoshji H, Gomez DE, Shibuya M, Thorgeirsson UP. Expression of vascular endo-thelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res 1996; 56:2013-2016.
Hsieh CY, Santell RC, Haslam SZ, Helferich WG. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998; 58:3833-3838. Erratum, Cancer Res 1999; 59:1388.
Whelan SL, Parkin DM, Masoyer E. Patterns of Cancer in Five Continents. WHO-IRAC. Lyon: IARC; 1990.
IRAC. Globocan 2002. [Online]. Available from http://www-depdb.iarc.fr/glob-ocan/GLOBOframe.htm 2004, Oct. 27.
Was this article helpful?